Patents by Inventor Nathalie Mantel

Nathalie Mantel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
    Patent number: 11471521
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: October 18, 2022
    Assignee: Sanofi Pasteur
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
    Patent number: 11452772
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: September 27, 2022
    Assignee: Sanofi Pasteur
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-Attenuated Yellow Fever Virus Strain Adapted to Grow on Vero Cells and Vaccine Composition Comprising the Same
    Publication number: 20220047692
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 17, 2022
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-Attenuated Yellow Fever Virus Strain Adapted to Grow on Vero Cells and Vaccine Composition Comprising the Same
    Publication number: 20210154289
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Application
    Filed: April 2, 2019
    Publication date: May 27, 2021
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • VACCINE COMPOSITIONS FOR PREVENTION AGAINST DENGUE VIRUS INFECTION
    Publication number: 20150265695
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: July 24, 2013
    Publication date: September 24, 2015
    Inventors: Jiansheng Yao, Yves Girerd-Chambaz, Isabelle Legastelois, Nathalie Mantel, Véronique Barban, Jean Lang, Bruno Guy